A Study of COVID-19 Patients Receiving Treatment With Nirmatrelvir; Ritonavir in the Kingdom of Saudi Arabia

A Study to Learn About the Patients With COVID-19 Prescribed Paxlovid in Morocco

NCT05997485 ·Status: WITHDRAWN

A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19

NCT05545319 ·Status: WITHDRAWN ·Phase: PHASE2

A Study to Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults Aged 60 and Older Living in Korean Long-term Care Hospitals Who Have COVID-19

NCT07089680 ·Status: NOT_YET_RECRUITING

Study to Evaluate the Clinical Outcomes in Adults With Covid-19 Who Have Been Treated With Remdesivir.

NCT04847622 ·Status: COMPLETED

Efficacy of Favipiravir in Treatment of Mild & Moderate COVID-19 Infection in Nepal

NCT04694612 ·Status: UNKNOWN ·Phase: PHASE3

A Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir

NCT05567952 ·Status: COMPLETED ·Phase: PHASE2

Effectiveness and Safety of New Oral Antivirals for COVID-19

NCT05894603 ·Status: UNKNOWN

RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID Symptoms

NCT05965726 ·Status: COMPLETED ·Phase: PHASE2

A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19

NCT05387369 ·Status: RECRUITING

Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19

NCT04358549 ·Status: COMPLETED ·Phase: PHASE2

Efficiency and Safety of Paxlovid for COVID-19 Patients With Severe Chronic Kidney Disease

NCT05938140 ·Status: UNKNOWN ·Phase: PHASE4

To Evaluate SSD8432/ Ritonavir in Adults With COVID-19

NCT05369676 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Defibrotide for the Treatment of Severe COVID-19

NCT04652115 ·Status: RECRUITING ·Phase: PHASE2

A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

NCT05487040 ·Status: TERMINATED ·Phase: PHASE1

ImPROving Quality of LIFe in the Long COVID Patient

NCT05823896 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Evaluation of Paxlovid for COVID-19: a Real-world Case-control Study

NCT05532852 ·Status: UNKNOWN ·Phase: NA

A Study to Understand How the Use of Paxlovid Affected Healthcare Use in People With Pre-existing Conditions.

NCT07090486 ·Status: COMPLETED

Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)

NCT04745351 ·Status: TERMINATED ·Phase: PHASE3

Favipiravir in High-risk COVID-19 Patients

NCT04818320 ·Status: COMPLETED ·Phase: PHASE3

A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection

NCT05047601 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19

NCT04336904 ·Status: UNKNOWN ·Phase: PHASE3

Appropriate Evaluation of Antiviral Therapy With Nirmatrelvir-ritonavir in Hospitalized Patients

NCT05749445 ·Status: UNKNOWN

A Study to Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19

NCT05386472 ·Status: TERMINATED ·Phase: PHASE1

EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19

NCT04960202 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Chance of Getting Severe COVID-19

NCT05890612 ·Status: RECRUITING